{
  "chapter": "Virology-Myxovirus",
  "questions": [
    {
      "q_no": 1,
      "question": "During an outbreak investigation in Kerala, India, several patients presented with fever and encephalitis. The outbreak is linked to contact with infected pigs, and fruit bats are abundant in the area. Laboratory analysis of patient samples reveals a paramyxovirus. The mortality rate is approximately 70%. Which of the following is the most likely diagnosis?",
      "options": {
        "A": "Japanese Encephalitis Virus",
        "B": "Nipah Virus",
        "C": "Rabies Virus",
        "D": "Eastern Equine Encephalitis"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Nipah Virus Explanation: The clinical presentation and history are indicative of the diagnosis of the NIPAH virus based on: Location (Kerala outbreak 2018) High mortality rate (60-70%) Clinical presentation (encephalitis) The presence of fruit bats and infected pigs Paramyxovirus identification NIPAH Virus Feature Details Key Facts (NIPAH) N - Nervous system affected I - Infection mortality 60-70% P - Pigs are amplifiers A - Animal-to-human transmission H - History of the outbreak in Kerala 2018 Transmission Cycle Vector: Fruit bats (natural reservoir) Intermediate host: Pigs (amplifiers) Human infection: Through contaminated food/water Patient secretions can spread disease Clinical Features Encephalitis (primary manifestation) Fever High mortality rate (60-70%) Neurological symptoms Diagnosis RT-PCR is the primary diagnostic test Sample: CSF or brain tissue Serology can be supportive Prevention Avoid contact with infected animals Proper handling of infected pig carcasses Avoid consuming contaminated fruits Protection from fruit bat secretions Japanese Encephalitis (Option A) has lower mortality and is mosquito-borne. Rabies (Option C) has a different transmission pattern and 100% mortality if untreated. EEE (Option D) has a different geographic distribution and vectors involved.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Myxovirus"
    },
    {
      "q_no": 2,
      "question": "A 4-year-old child presents with fever, cough, conjunctivitis, and spots on the buccal mucosa as shown below after a recent family trip. The mother reports no vaccinations. Which statement best describes the incubation period and transmission mode of the suspected illness?",
      "options": {
        "A": "Incubation period: 1-2 days; bloodborne transmission",
        "B": "Incubation period: 10-14 days; respiratory droplets",
        "C": "Incubation period: 3-5 days; contaminated surfaces only",
        "D": "Incubation period: 7-8 days; direct skin contact"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Incubation period: 10-14 days; respiratory droplets Explanation : The incubation period of measles typically ranges from 10 to 14 days and spreads primarily through respiratory droplets, making it highly contagious. Incubation Period and Transmission of Measles: Incubation Period: Average Duration : 10 days in children 21 days in adults. Transmission: Primarily transmitted through the respiratory route by: Droplet Inhalation : Commonly over short distances, in close settings. Aerosol Transmission : Small-particle aerosols can remain airborne for extended periods, especially in enclosed public spaces like schools and hospitals, facilitating longer-range transmission. Pathogenesis and Spread: Primary Site of Infection : Respiratory tract. Virus Spread : Begins with local replication in the respiratory tract. Primary Viremia : Virus moves to regional lymph nodes. Secondary Viremia : Virus enters the bloodstream, leading to widespread distribution throughout the body. Target Organs : Measles virus predominantly affects epithelial surfaces, including the skin, respiratory tract, and conjunctiva. Measles does not spread through blood, and the incubation is much longer than 1-2 days. (Option A) Although surfaces can carry the virus briefly, respiratory droplets are the primary transmission route. (Option C) Direct skin contact is not a transmission method for measles; the incubation period is usually longer than 7-8 days. (Option D) Reference: Essentials of Medical Microbiology by Apurba Shastry, 3rd Edition, Page 559, 560.",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmicrobiology/Virology-Myxovirus_Q2_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Virology-Myxovirus"
    },
    {
      "q_no": 3,
      "question": "A 75-year-old female presents to the clinic with symptoms of high fever, chills, cough, body aches, and fatigue. She has a history of hypertension and chronic kidney disease. She reports she has never received an influenza vaccine. The patient is worried about her symptoms and potential complications. Which of the following statements about influenza vaccination is most appropriate for this patient? elderly individuals.",
      "options": {
        "A": "She should receive the live attenuated influenza vaccine (LAIV) because it is more effective for",
        "B": "She should avoid the influenza vaccine because of her chronic kidney disease.",
        "C": "She should receive the high-dose inactivated influenza vaccine (HD-IIV) to provide better protection.",
        "D": "Influenza vaccination is not recommended for individuals above 65 years old."
      },
      "correct_answer": "C",
      "explanation": "provide better protection. Correct Answer: C) She should receive the high-dose inactivated influenza vaccine (HD-IIV) to provide better protection. Explanation: Influenza vaccines, commonly known as flu shots, are designed to protect against infection by influenza viruses. Types of Influenza Vaccines Inactivated Influenza Vaccines (IIVs): These vaccines contain killed influenza viruses and are given as a shot (injection). They are approved for use in people aged 6 months and older. Examples include Fluarix and Fluzone. Live Attenuated Influenza Vaccine (LAIV): This vaccine contains weakened live influenza viruses and is given as a nasal spray. It is approved for use in people aged 2 through 49 years. It is not recommended for pregnant women, immunocompromised individuals, or people with certain medical conditions. High-Dose Influenza Vaccine (HD-IIV): This vaccine contains four times the amount of antigen compared to a regular flu shot, providing better protection for people aged 65 and older. An example is Fluzone High-Dose. Cell-Based Influenza Vaccines: These vaccines are grown in mammalian cell cultures instead of chicken eggs, making them suitable for people with egg allergies. An example is Flucelvax. Recombinant Influenza Vaccine (RIV): This vaccine is produced using recombinant DNA technology and does not require the use of the influenza virus or eggs in the production process. Types and important features of Influenza vaccines: Trivalent Vaccines: These vaccines protect against three different influenza viruses (two influenza A viruses- H1N1 and H3N2 and one influenza B virus). Quadrivalent Vaccines: These vaccines protect against four different influenza viruses (two influenza A viruses and two influenza B viruses). Annual Vaccination: Influenza vaccines are updated each year to match the strains predicted to be most common during the upcoming flu season. Formulations : Inactivated Influenza Vaccine (IIV) : Injectable, the most widely used, suitable for anyone older than six months. Cell Culture-Based Vaccine (ccIIV) : Produced in cell cultures rather than eggs, making it suitable for those with severe egg allergies. Recombinant Influenza Vaccine (RIV) : Contains recombinant hemagglutinin proteins and is completely egg-free. Live Attenuated Influenza Vaccine (LAIV) : A nasal spray form containing a weakened virus, suitable for healthy individuals aged 2-49, not recommended for high-risk groups. Benefits of Influenza Vaccination Reduces Risk of Illness Prevents Complications Community Protection. Reference: https://www.emro.who.int/health-topics/influenza/influenza-vaccines.html https://www.uptodate.com/con tents/seasonal-influenza-vaccination-in-adults?search=influenza%20vaccines&source=search_result&selectedTitle =2%7E150&usage_type=default&display_rank=1 https://www.uptodate.com/contents/seasonal-influenza-in-childr",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Myxovirus"
    },
    {
      "q_no": 4,
      "question": "A 3-year-old child presents with acute onset of barking cough, hoarseness, and mild respiratory distress that worsens at night. Physical examination reveals inspiratory stridor but normal lung fields. The child attends preschool where several other children have similar symptoms. The illness started with mild upper respiratory symptoms 2 days ago. No other significant clinical findings are seen. Which of the following viruses is most likely responsible for this presentation?",
      "options": {
        "A": "Adenovirus",
        "B": "Respiratory Syncytial Virus",
        "C": "Parainfluenza Virus Type 2",
        "D": "Measles Virus"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Parainfluenza Virus Type 2 Explanation: Parainfluenza virus type 2 is the correct diagnosis based on: Age group: Preschool child Classic croup symptoms: Barking cough, stridor, hoarseness Pattern: Starts with URI symptoms progressing to croup Epidemiology: Multiple cases in a preschool setting Parainfluenza Virus Clinical Features Croup (Types 1 and 2) Lower respiratory disease (Type 3) Mild respiratory illness (Type 4) Adults: mild URI, hoarseness Rarely causes parotitis Epidemiology Type 3: Common in the first year of life Types 1 & 2: Preschool children First infections more serious 50% of infants become seropositive by 12 months Laboratory Diagnosis Specimen: Throat/nasal swabs Virus isolation: Monkey kidney cells Serology: Paired sera samples PCR: Most rapid and sensitive Transmission Air/respiratory droplets Through fingers Nosocomial spread uncommon No vaccine available Adenovirus typically causes pharyngitis, fever, and conjunctivitis rather than croup ( Option A) RSV typically causes bronchiolitis with wheezing rather than croup ( Option B) Measles presents with characteristic rash and Koplik spots ( Option D) Reference: Ananthnarayan & Paniker’s Textbook of Microbiology 10th Edition Page 515, 516",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Myxovirus"
    },
    {
      "q_no": 5,
      "question": "A 3-month-old infant is brought to the emergency department with progressive respiratory distress, cough, and rhinorrhea during winter. The child attends daycare, and several other infants there have similar symptoms. Physical examination reveals tachypnea, wheezing, and bilateral crackles. Further testing is done, and the patient is diagnosed with Respiratory Syncytial Virus. Which of the following statements regarding RSV infection in this case is most accurate?",
      "options": {
        "A": "PCR testing is insensitiv,e but viral culture is the gold standard",
        "B": "Maternal antibodies provide complete protection at this age",
        "C": "The peak incidence occurs at 2-3 months of age with increased hospitalization risk",
        "D": "Live-attenuated vaccine is recommended for prevention"
      },
      "correct_answer": "C",
      "explanation": "risk Correct Answer: C) The peak incidence occurs at 2-3 months of age with increased hospitalization risk Explanation: RSV shows peak incidence at 2-3 months of age when infants are particularly vulnerable to severe disease requiring hospitalization. Respiratory Syncytial Virus Epidemiology Global distribution Winter epidemics in temperate regions Peak age: 2-3 months Common in daycares, nurseries Incubation period: 4-6 days Transmission Close Contact Contaminated fingers and fomites Respiratory droplets Virus shedding: 1-3 weeks Clinical Features Most infections symptomatic Range from mild to severe respiratory illness 25-40% develop lower respiratory involvement Hospitalization rate: ~1% Recovery usually in 1-2 weeks Diagnosis Specimen: Nasopharyngeal swabs PCR: Sensitive and rapid( Option A) Immunofluorescence tests Serology: Paired samples for antibody titers Treatment Primarily supportive care Ribavirin for severe cases Palivizumab is a respiratory syncytial virus f protein monoclonal antibody and is used in severe cases in children. No effective vaccine available( Option D) Risk Factors Age < 6 months, Since maternal antibodies provide only partial protection and decline by 2-3 months (Option B) Prematurity Immunodeficiency Cardiac defects Reference: Ananthnarayan & Paniker’s Textbook of Microbiology, 10th Edition, Page 516, 517",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Myxovirus"
    },
    {
      "q_no": 6,
      "question": "A 6-year-old boy presents with bilateral painful swelling in the region of his parotid glands that began 2 days ago. His mother notes that the pain worsens when he drinks orange juice. He had a fever of 101.2°F (38.4°C) before the swelling appeared. The patient's vaccination status is unknown. During examination, bilateral parotid enlargement is noted. Which of the following is the most specific diagnostic test to confirm the suspected infection in this patient?",
      "options": {
        "A": "Serum IgG antibody test",
        "B": "Viral culture from parotid secretions",
        "C": "RT-PCR from buccal swab",
        "D": "Physical examination findings alone"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) RT-PCR from buccal swab Explanation: The case presents classic symptoms of mumps : bilateral parotitis with pain that increases with citrus juice consumption (stimulation of salivary glands), along with fever as a prodromal symptom. RT-PCR from a buccal swab is the most specific diagnostic test for confirming acute mumps infection, especially when collected early in the course of illness. Diagnosis Methods RT-PCR Buccal swab Most specific test Collect within first 3 days Antigen ELISA method Used for rapid",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmicrobiology/Virology-Myxovirus_Q6_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Virology-Myxovirus"
    },
    {
      "q_no": 7,
      "question": "A 15-year-old boy presents with a 3-day history of fever, headache, and bilateral parotid gland swelling. He reports no recent vaccinations. Physical examination reveals painful, swollen parotid glands and lab tests show elevated serum amylase. Which complication is most likely to develop if the condition progresses?",
      "options": {
        "A": "Orchitis",
        "B": "Encephalitis",
        "C": "Hearing loss",
        "D": "Pancreatitis"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Orchitis Explanation: The diagnosis of mumps is supported by the patient's presentation of bilateral parotitis, fever, and elevated serum amylase levels, along with a lack of recent vaccinations. The most likely complication is orchitis, as it occurs in 20-30% of post-pubertal males with mumps and is more common than other potential complications such as encephalitis or pancreatitis. Mumps: It is a viral infection primarily affecting the parotid glands, with the mumps virus being the most common cause of parotid gland enlargement in children. Severe cases can lead to complications such as orchitis and aseptic meningitis. Epidemiology: Mumps is endemic worldwide, peaks in winter and spring, and is often associated with unvaccinated individuals in overcrowded areas. Approximately 500,000 cases are reported globally each year. Immunization has significantly reduced the incidence. Primarily affects children aged 5–9 years . However, adults without immunity can also contract the disease, with potentially more severe outcomes. Lifelong immunity usually follows either natural infection or vaccination, with a high secondary attack rate of 86% in close contacts. Transmission: Respiratory Route Spread occurs through respiratory droplets, saliva, and fomites contaminated by the virus. Incubation Period About 19 days, with a range from 7 to 23 days. Infectivity Patients are contagious from 1 week before symptoms to 1 week after. The peak infective period is 1–2 days before symptoms begin. Source Both clinical and subclinical cases are infectious, with subclinical cases (30–40% of infections) helping sustain transmission. Reservoir Humans are the only known reservoir, with no carrier state identified. Clinical Features: Up to 50% of infected individuals show mild or no symptoms. Parotitis The most common specific feature, presenting in 70–90% of cases, is usually bilateral parotid swelling. Orchitis/Epididymo-orchitis Seen in 15–30% of postpubertal males, usually unilateral; infertility is rare due to unilateral involvement. Aseptic Meningitis Occurs in less than 10% of cases, typically self-limiting, but can cause permanent deafness if cranial nerves are affected. Oophoritis Found in about 5% of infected women. Pancreatitis Affects approximately 4% of cases, leading to diabetes in rare cases. Atypical Presentation Some patients may present with aseptic meningitis without parotitis (in 10% of cases). Encephalitis (Option B) is rare, affecting less than 0.3% of mumps cases, mainly in younger children. Hearing loss (Option C) can occur but is extremely rare (1 in 20,000 cases). Pancreatitis (Option D) is possible but less common in adolescents compared to orchitis. Reference: Essentials of Medical Microbiology by Apurba Shastry, 3rd Edition, Page 656, 657.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Myxovirus"
    },
    {
      "q_no": 8,
      "question": "A 9-month-old infant presents with high fever, cough, conjunctivitis, rash over the buccal mucosa, and a spreading maculopapular rash. What is the most appropriate next step in management?",
      "options": {
        "A": "Administer the vaccine",
        "B": "Prescribe antiviral therapy",
        "C": "Administer immunoglobulin therapy",
        "D": "Educate on supportive care and schedule the vaccine at 12 months"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Administer immunoglobulin therapy Explanation: The infant is symptomatic and unvaccinated; immunoglobulin within 6 days of exposure can reduce measles severity. Vaccination is ineffective post-exposure, and there is no specific antiviral therapy. Deferring until 12 months without prophylaxis increases risk. Diagnosis of Measles: Specimens for Testing : Preferred samples include nasopharyngeal swab, conjunctival swab, blood, respiratory secretions, and urine. Antigen Detection : Detectable by using direct immunofluorescence with anti-nucleoprotein antibodies applied to infected cells. Highly specific for diagnosing acute measles infections. Virus Isolation : Monkey or human kidney cells are the standard cell lines used. Viral growth is characterized by the presence of Warthin-Finkeldey cells —multinucleated giant cells containing intranuclear and intracytoplasmic inclusions. Shell vial culture is a quicker alternative, allowing early detection within 2-3 days. Antibody Detection : The presence of measles-specific IgM in serum or oral fluid, or a four-fold rise in IgG titer between acute and convalescent-phase sera is diagnostic. Anti-measles antibody levels in cerebrospinal fluid (CSF) are diagnostic for subacute sclerosing panencephalitis (SSPE). RT-PCR : Reverse-transcription PCR can detect measles RNA (e.g., nucleoprotein gene) with high sensitivity and specificity. Useful for tracking measles strains and conducting epidemiological studies. Detectable RNA persists longer than the virus itself (10–14 days post-rash). Vaccination: Vaccine Types : Live attenuated vaccine : Strains used : Schwartz, Edmonston-Zagreb, Moraten strains. Prepared in chick embryo cell lines . Vaccine Formulation : Available as MR (measles-rubella) , MMR (measles, mumps, rubella) , and MMR-V (measles, mumps, rubella, varicella) vaccines. Stored at –20°C due to its thermolabile nature. Dosing Schedule : India’s Immunization Schedule : First dose of MR at 9-12",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmicrobiology/Virology-Myxovirus_Q8_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Virology-Myxovirus"
    },
    {
      "q_no": 9,
      "question": "A 3-year-old unvaccinated child presents with high fever, cough, conjunctivitis, and a maculopapular rash that began on the face and has spread to the trunk and limbs. Oral examination reveals small, white lesions on the buccal mucosa. Which complication is most likely to develop in the acute phase of this illness?",
      "options": {
        "A": "Acute encephalitis",
        "B": "Otitis media",
        "C": "Subacute sclerosing panencephalitis (SSPE)",
        "D": "Pneumonia"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Pneumonia Explanation: Pneumonia is the leading cause of morbidity and mortality in acute measles and is the most likely immediate complication in this case, especially in an unvaccinated child. Measles is an acute, highly contagious viral infection caused by the measles virus, a member of the Paramyxoviridae family. It primarily affects children and is transmitted through respiratory droplets or small-particle aerosols . Clinical Stages of Measles: Stage Duration Symptoms Incubation Period 10 days (up to 21 days) Asymptomatic phase; the virus multiplies in the respiratory tract, followed by primary and secondary viremia. Prodromal Stage 4 days Fever (day 10), Koplik’s spots (day 12), non-specific symptoms (cough, coryza, conjunctivitis). Eruptive Stage 4 days post fever The maculopapular rash appears first behind the ears, then spreads to the face, trunk, and limbs, fading in the same order. Post-measles Stage Variable Characterized by weight loss, weakness, and a risk of progressing to chronic conditions. Complications of Measles: A. Secondary Bacterial Infections Immune suppression following measles increases susceptibility to bacterial infections. Otitis media and bronchopneumonia are the most frequent bacterial complications. Worsening of underlying tuberculosis with a possible false-negative Mantoux test . B. Complications Due to Measles Virus Itself Giant-cell pneumonitis (Hecht’s pneumonia), primarily in immunocompromised and HIV-infected individuals. Acute laryngotracheobronchitis (croup). Diarrhea leading to malnutrition and vitamin A deficiency. C. Central Nervous System (CNS) Complications Subacute sclerosing panencephalitis (SSPE) : A rare but severe late complication characterized by progressive CNS deterioration. Other CNS complications include post-measles encephalomyelitis and measles inclusion body encephalitis . Acute encephalitis (Option A): Occurs in approximately 1 in 1,000 cases, often presenting later with neurological symptoms, not during the acute phase. Otitis media (Option B): It is common but typically less severe than pneumonia in terms of immediate risk. SSPE (Option C): It is a delayed complication, developing years after initial infection, thus not relevant to the acute phase. Reference: Essentials of Medical Microbiology by Apurba Shastry, 3rd Edition, Page 560.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Myxovirus"
    },
    {
      "q_no": 10,
      "question": "A patient comes to the clinic with symptoms of a viral infection. The physician is reviewing potential viruses based on their classification into myxovirus families. Which of the following viruses is NOT a member of the Paramyxoviridae family?",
      "options": {
        "A": "Measles virus",
        "B": "Parainfluenza virus",
        "C": "Influenza virus",
        "D": "Mumps virus"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Influenza virus Explanation: The influenza virus belongs to the Orthomyxoviridae Family , which is distinct from Paramyxoviridae. Influenza viruses are responsible for seasonal flu and can lead to severe respiratory illness. Myxovirus Myxoviruses bind to mucin receptors on RBCs, causing hemagglutination. Most myxoviruses are respiratory pathogens. Divided into two families: Orthomyxoviridae Contains segmented RNA. Important human pathogen: Influenza viruses (cause URTIs, rare pneumonia). Paramyxoviridae Includes several viruses: Parainfluenza virus: causes laryngotracheobronchitis and URTIs. (Option B) Mumps virus: causes parotitis in children; rare complications include meningitis. (Option D) Measles virus: causes exanthematous lesions; rare CNS complications. (Option A) Respiratory syncytial virus: causes acute bronchiolitis in infants. Metapneumovirus: causes URTIs. Zoonotic viruses: Nipah and Hendra (mainly cause encephalitis). Properties Orthomyxoviridae Paramyxoviridae Size 80-120 nm 100-300 nm Shape Spherical; Rarely filamentous Pleomorphic Nucleic acid Negative sense ssRNA, Segmented; eight pieces Negative sense ssRNA Unsegmented; single piece Genetic recombination Seen Not seen Antigenic variation Seen Not seen Site for RNA Replication Nucleus Cytoplasm Important human pathogens Influenza virus Parainfluenza virus, Mumps virus Respiratory syncytial virus Measles virus, Metapneumovirus Antigens: Hemagglutinin (HA) and Neuraminidase (NA) Both HA and NA spikes are present, So hemagglutination is reversible (Elution seen) HA spike present in Parainfluenza, Mumps, Measles, NA spike present in Parainfluenza, Mumps Inclusion body : Intracytoplasmic (only for measles, it is both intracytoplasmic and intranuclear) Reference: Ananthanarayan and Paniker’s Textbook of Microbiology, 10th Edition, Page Mahon Lehman Textbook of Diagnostic Microbiology, 6th edition, Page Apurba Sastry Essentials of Medical Microbiology, 3rd Edition Page",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Myxovirus"
    },
    {
      "q_no": 11,
      "question": "A 30-year-old healthcare worker presents with sudden onset fever, chills, sore throat, and muscle aches. She reports exposure to multiple patients with similar symptoms. The physician suspects influenza and requests a diagnostic test for confirmation. A nasopharyngeal swab is collected, and a Hemagglutination Inhibition (HI) test is performed. The results show a significant increase in antibody titers in the second sample compared to the first sample, taken 10 days apart. Which of the following best explains the findings and indicates a confirmed diagnosis of influenza?",
      "options": {
        "A": "The HI test shows no change in antibody titers between the first and second samples.",
        "B": "The HI test shows a fourfold increase in antibody titers between the first and second samples.",
        "C": "The HI test shows a twofold decrease in antibody titers between the first and second samples.",
        "D": "The HI test shows a single positive result with no subsequent titer testing."
      },
      "correct_answer": "B",
      "explanation": "second samples. Correct Answer: B) The HI test shows a fourfold increase in antibody titers between the first and second samples. Explanation : The Hemagglutination Inhibition (HI) test is a specific serological test used to detect antibodies against influenza viruses. This test measures the ability of patient antibodies to inhibit the agglutination (clumping) of red blood cells by the influenza virus. For a confirmed influenza infection, a fourfold or greater rise in antibody titers between acute (initial) and convalescent (second) serum samples taken 7–14 days apart is indicative of an active or recent infection. The increase in titers reflects the body’s immune response to the infection. Lab Diagnosis of Influenza: The laboratory diagnosis of influenza involves various methods for detecting the virus or its antibodies. These methods include: Specimen Collection and Transport Ideal specimens include nasopharyngeal swabs, nasal aspirates, or lavage fluids. Swabs with synthetic tips (polyester or Dacron) are recommended. Specimens are placed in viral transport media, stored at 4°C if processed within 4 days, and at -70°C if stored longer. Virus Isolation Influenza virus can be inoculated in embryonated eggs. Growth detection occurs through hemadsorption or hemagglutination. Primary monkey kidney cell lines are also used to grow influenza viruses for detection. Direct Immunofluorescence Test (IF) This rapid method involves staining viral antigens on epithelial cells with fluorescent antibodies. However, it has lower sensitivity than virus isolation. Molecular Methods Reverse Transcriptase PCR (RT-PCR) : Highly sensitive and specific, detecting influenza RNA quickly. Real-Time RT-PCR : The preferred diagnostic method due to its quantitative capability and ability to detect multiple seasonal strains, including A/H1N1, A/H3N2, and influenza B. Serological Methods for Antibody Detection Hemagglutination Inhibition Test (HAI) : Previously used for influenza, HAI measures specific antibodies by detecting their ability to inhibit virus-induced hemagglutination. Enzyme-Linked Immunosorbent Assay (ELISA) and Neutralization Test : ELISA is commonly used to detect serum antibodies against influenza antigens, particularly for epidemiological studies. Hemagglutination Inhibition (HAI) Test: The HAI test is a serological method used primarily in epidemiology to detect antibodies against influenza viruses. Principle : Influenza viruses possess hemagglutinin (HA) proteins, allowing them to agglutinate red blood cells (RBCs). Specific antibodies in a patient’s serum can inhibit this agglutination. The test measures these antibodies’ ability to prevent hemagglutination. Procedure : Step 1 : Diluted serum samples are added to standardized",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Myxovirus"
    },
    {
      "q_no": 12,
      "question": "A 67-year-old patient with COPD presents with high fever, chills, myalgia, and dry cough, which started suddenly. Influenza A is confirmed by a rapid test. He missed his annual influenza vaccine this year. What is the best next step in management?",
      "options": {
        "A": "Start Oseltamivir immediately",
        "B": "Prescribe supportive care only, as antivirals are not effective beyond 48 hours.",
        "C": "Administer high-dose azithromycin",
        "D": "Recommend the influenza vaccine now to prevent the progression of symptoms"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer : A) Start Oseltamivir immediately Explanation : Oseltamivir is indicated for influenza treatment, especially in patients at high risk for complications, such as older adults and those with COPD. Prompt initiation within 48 hours is ideal but may also be effective if started later in severe cases. Antiviral therapy in high-risk groups reduces symptom duration and the risk of complications, like pneumonia. Clinical Features of Influenza: Incubation Period : 18–72 hours, depending on viral load and host immunity. Symptoms : Starts with minor upper respiratory symptoms like chills, dry cough, and headache. Progresses to high-grade fever, myalgia, fatigue, and appetite loss. Most cases are self-limiting and resemble other upper respiratory infections, such as the common cold. Complications : Secondary Bacterial Pneumonia : The most common complication, caused by bacteria like Staphylococcus , Streptococcus pneumoniae , and Haemophilus influenzae . Primary Influenza Pneumonia : Less common but more severe, especially in high-risk groups. Exacerbation of Chronic Conditions : Can worsen conditions like COPD and asthma. Reye’s Syndrome : A rare but serious condition in children causing liver damage and encephalopathy, due to aspirin use during viral infections. Other Complications : Include myocarditis, encephalitis, myositis, and Guillain-Barré syndrome, mainly in severe cases I . Treatment: Antiviral Drugs : Neuraminidase Inhibitors : Oseltamivir (Tamiflu) : Oral; for both Influenza A and B; recommended within 48 hours of symptom onset. Zanamivir : Inhaled formulation, suitable for both Influenza A and B; effective for patients who can use inhalation. Peramivir : Intravenous option for severe cases when other drugs are not viable. Mechanism : Neuraminidase inhibitors block the viral enzyme neuraminidase, which prevents the release of new viral particles, slowing down virus spread in the respiratory tract. Symptomatic Treatment : Antipyretics (acetaminophen) for fever. Adequate hydration is to manage fluid loss from fever and respiratory symptoms I . Vaccination: Types of Vaccines : Trivalent Vaccine (TIV) : Protects against three strains—H1N1, H3N2, and one B strain. Quadrivalent Vaccine (QIV) : Covers an additional B strain, broadening protection. Formulations : Inactivated Influenza Vaccine (IIV) : Injectable, the most widely used, suitable for anyone older than six months. Cell Culture-Based Vaccine (ccIIV) : Produced in cell cultures rather than eggs, making it suitable for those with severe egg allergies. Recombinant Influenza Vaccine (RIV) : Contains recombinant hemagglutinin proteins and is completely egg-free. Live Attenuated Influenza Vaccine (LAIV) : A nasal spray form containing a weakened virus, suitable for healthy individuals aged 2-49, not recommended for high-risk groups. Vaccination Schedule : Annual vaccination is recommended due to frequent mutations (antigenic drift) in the virus. Immunity lasts 6-12 months, with optimal vaccination time before the flu season onset. Prescribe supportive care only (Option B) : While supportive care (hydration, antipyretics) is important, antiviral therapy is recommended in high-risk patients, even if initiated after 48 hours, due to potential benefits in reducing",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Myxovirus"
    },
    {
      "q_no": 13,
      "question": "A 50-year-old patient presents to the clinic with flu-like symptoms during the winter months. The physician discusses the different types of influenza viruses with the patient, emphasizing their characteristics and impacts on public health. Which of the following statements about influenza viruses discussed by the physician is FALSE?",
      "options": {
        "A": "Influenza A has 18 HA and 11 NA subtypes.",
        "B": "Influenza B is classified into subtypes based on its HA and NA proteins.",
        "C": "Influenza A is known to cause both seasonal epidemics and pandemics.",
        "D": "Influenza C rarely causes severe illness in humans and has a low public health impact."
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Influenza B is classified into subtypes based on its HA and NA proteins. Influenza Antigenic Subtypes and Nomenclature Genera: Influenza viruses are divided into types A, B, C, and D based on RNP and M proteins. Subtypes : Influenza A: Has 18 HA (H1–H18) and 11 NA (N1–N11) subtypes. (Option A ruled out) Six HA (H1, H2, H3, H5, H7, H9) and two NA (N1, N2) subtypes have been found in humans. Most subtypes primarily infect animals and birds, but some infect humans, causing epidemics/pandemics. (Option C ruled out) Influenza B: No subtypes but has two main lineages—B/Yamagata and B/Victoria. (Option B) Influenza C: Rarely causes infection, is mild in nature, and has low public health impact. (Option D ruled out) Influenza D: Primarily infects cattle and does not infect humans. Nomenclature : Standard naming format includes virus type/host (for non-human origin)/geographical origin/strain number/year/(HA NA subtype). Human strain example : Influenza A/Hong Kong/03/1968 (H3N2). Non-human strain example: Influenza A/swine/Iowa/15/1930 (H1N1). Epidemiology Seasonal Epidemics: Occur almost annually, with varying severity. Incidence : Approximately 3–5 million severe cases and 300,000–600,000 deaths globally each year. Pandemics : Occur every 10–40 years with novel influenza A subtypes, often causing higher mortality. Seasonality : Common in winter, with dominant strains differing by season and location. Annual Attack Rate : 5–10% in adults and 20–30% in children. Pattern : Influenced by the nature of antigenic variation in influenza types (antigenic drift and shift). Reference: Apurba Sastry Essentials of Medical Microbiology, 3rd Edition Page 649, 650",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Myxovirus"
    },
    {
      "q_no": 14,
      "question": "Which statement correctly describes antigenic drift and antigenic shift in influenza viruses?",
      "options": {
        "A": "Drift causes pandemics; shift causes minor epidemics.",
        "B": "Drift involves minor mutations; shift involves genetic reassortment.",
        "C": "Shift occurs in Influenza A and B; drift occurs only in Influenza A.",
        "D": "Drift produces a new strain; shift evades immune recognition."
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Drift involves minor mutations; shift involves genetic re-assortment. change due to genetic re-assortment. Antigenic Drift Antigenic Shift Minor change due to point mutations in HA/NA genes, altering amino acid sequences and helping the virus partially evade immune recognition. (Option D) Requires two or more mutations for significant impact. Occurs in both influenza A and B viruses. (Option C) Leads to outbreaks and minor epidemics, occurring every 2–3 years. (Option A) An abrupt, major change in HA/NA genes due to genetic reassortment between influenza viruses infecting the same host. Produces a new virus strain, making prior antibodies ineffective. (Option D) Occurs only in influenza A virus. (Option C) Causes pandemics and major epidemics, with shifts happening every 10–20 years (e.g., the H1N1 pandemic of 2009). (Option A)",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmicrobiology/Virology-Myxovirus_Q14_exp.png",
      "chapter_heading": "Virology-Myxovirus"
    },
    {
      "q_no": 15,
      "question": "A 45-year-old man visits the emergency department with complaints of high fever, severe headache, and muscle aches that started 24 hours ago. He mentions he has been feeling increasingly fatigued and has developed a dry cough. Which of the following statements about the virus causing his symptoms is true? only.",
      "options": {
        "A": "Amantadine acts against both A and B strains of the virus whereas Oseltamivir acts against strain A",
        "B": "The incubation period for the virus is 7 to 14 days.",
        "C": "The immune response mainly involves antibodies against the hemagglutinin protein.",
        "D": "Once infected, individuals develop lifelong immunity against all strains of the virus."
      },
      "correct_answer": "C",
      "explanation": "protein. Correct Answer: C) The immune response mainly involves antibodies against the hemagglutinin protein. Explanation: The patient's symptoms of high fever, severe headache, muscle aches, and dry cough, along with the rapid onset of these symptoms, strongly suggest influenza caused by an orthomyxovirus. The presentation aligns with typical flu manifestations, particularly in the context of recent respiratory illness. The immune response to orthomyxoviruses primarily involves humoral immunity with antibodies targeting HA and neuraminidase (NA). Orthomyxovirus Pathogenesis: Transmission : Through inhalation of respiratory droplets within 1 meter or contact with infected surfaces followed by touching the nose, eyes, or mouth. Target Cell Entry : Viral HA binds to sialic acid receptors on respiratory mucosa for viral entry. Replication and Spread : The virus replicates locally in infected cells, spreading to adjacent cells; rarely spreads to the lower respiratory tract or bloodstream. Local Damage : Causes cellular destruction and desquamation of respiratory mucosa, increasing susceptibility to secondary bacterial infections. Immune Response : Humoral immunity predominates with antibodies against HA and NA providing subtype-specific protection, but reinfection can still occur. (Option D ruled out) Clinical Manifestations: Incubation Period : Typically 18–72 hours, depending on viral load and host immunity. (Option B ruled out) Uncomplicated Influenza (Flu Syndrome) : Often presents as chills, headache, dry cough, high-grade fever, myalgia, and anorexia; usually self-limiting. Complications: Pneumonia : Secondary bacterial pneumonia (common agents include staphylococci, pneumococci, Haemophilus influenzae) or, rarely, primary influenza pneumonia. Other Respiratory Complications : Exacerbation of COPD, chronic bronchitis, bronchiolitis, otitis media, parotitis, asthma. Extrapulmonary Complications : Myositis, rhabdomyolysis, myocarditis, encephalitis, and Guillain-Barre syndrome. Reye’s Syndrome : Liver degeneration and acute encephalopathy in children following aspirin use with influenza B, varicella-zoster, or rarely influenza A. Treatment (Option A ruled out) Neuraminidase Inhibitors : Drugs like oseltamivir, zanamivir, and peramivir are effective for influenza A and B; start within 48 hours of symptom onset. Schedule: Twice daily for 5 days (treatment); once daily (chemoprophylaxis for 7 days). M2 Inhibitors: Amantadine and rimantadine were used for some influenza A strains; resistance was noted in certain strains like A/H1N1 and A/H5N1. Reference: Apurba Sastry Essentials of Medical Microbiology, 3rd Edition Page 649,650,654",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Myxovirus"
    },
    {
      "q_no": 16,
      "question": "Match each structure of the Orthomyxovirus (Influenza Virus) with its corresponding function. 1. Hemagglutinin (HA) A) Forms ion channels in the envelope 2. Neuraminidase (NA) B) Responsible for RNA transcription and replication 3. Polymerase proteins (PB1, PB2, PA) C) Aids in viral release and prevents virion aggregation 4. Nucleoprotein D) Binds sialic acid receptors for viral entry 5. Matrix protein - M1 E) Forms a shell beneath the envelope 6. Matrix protein - M2 F) Forms a ribonucleoprotein complex with viral RNA",
      "options": {
        "A": "1-D, 2-C, 3-B, 4-E, 5-F, 6-A",
        "B": "1-B, 2-D, 3-C, 4-F, 5-E, 6-A",
        "C": "1-D, 2-C, 3-B, 4-F, 5-E, 6-A",
        "D": "1-C, 2-B, 3-A, 4-D, 5-F, 6-E"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) 1-D, 2-C, 3-B, 4-F, 5-E, 6-A Explanation: Orthomyxovirus (Influenza Virus) Segments and Structure: Genera: Includes influenza A, B, C, and D viruses. Genome Segments : Influenza A and B: Eight segments of negative-sense, single-stranded RNA. Influenza C and D: Seven segments (lacking the segment coding for neuraminidase). Shape and Size : Spherical, approximately 80–120 nm in diameter. Helical symmetry with a helical nucleocapsid enclosed in an envelope. Replication Site : Unique among RNA viruses, replication occurs in the nucleus. Viral Proteins : Structural Proteins : Polymerase proteins: PB1, PB2, and PA are responsible for RNA transcription and replication. Nucleoprotein (NP): Forms a ribonucleoprotein complex with viral RNA. Matrix proteins: M1 forms a shell beneath the envelope; M2 forms ion channels in the envelope. Glycoproteins: Hemagglutinin (HA) binds sialic acid receptors for viral entry; Neuraminidase (NA) aids in viral release and prevents virion aggregation. Non-structural Proteins : NS1 acts as an interferon antagonist. NS2 aids in nuclear export. Envelope : Lipid envelope containing HA and NA glycoproteins, which are essential for host cell entry and virus release. Hemagglutinin: Triangular-shaped peplomer. Binds to mucin or sialic acid receptors on respiratory epithelial cells. Facilitates viral entry into host cells. Neuraminidase: Mushroom-shaped and present in fewer numbers than HA. Sialidase enzyme that degrades sialic acid receptors on host cells. Facilitates release of virus particles from infected cell surfaces during budding. Prevents self-aggregation of virions to host cells. Helps the virus pass through the mucin layer in the respiratory tract to reach target epithelial cells.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Myxovirus"
    },
    {
      "q_no": 17,
      "question": "A medical student is studying viral classifications and comes across various RNA virus families. The student needs to identify misconceptions regarding the properties of these viruses. Which of the following statements is FALSE?",
      "options": {
        "A": "Coronaviridae and Flaviviridae are examples of positive-sense RNA viruses.",
        "B": "Bunyavirus has segmented RNA with 7 segments.",
        "C": "Orthomyxovirus contains segmented RNA with 7-8 segments.",
        "D": "Rhabdovirus and Myxovirus are examples of negative-sense RNA viruses."
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Bunyavirus has segmented RNA with 7 segments. Explanation: Bunyavirus has 3 segments of RNA, not 7. All other statements about the respective virus families and their properties are true. Some examples of: Positive sense Negative sense Picornaviridae Flaviviridae Togaviridae Hepeviridae Coronaviridae (Option A ruled out) M: Myxovirus R: Rhabdovirus (Option D ruled out) F: Filovirus A: Arenavirus B: Bunyavirus Segmented RNA - BIRA Bunyavirus- 3 segments Orthomyxovirus (Influenza)- 7-8 segments (Option C ruled out) Reovirus- 10-12 segments Arenavirus- 2 segments Reference: Apurba Sastry Essentials of Medical Microbiology, 3rd Edition Page 82-84 Introduction to RNA Viruses - PMC",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Myxovirus"
    }
  ]
}
